){kind=logo}
Loeb & Loeb represented Archimedes Tech SPAC Partners II Co., a special purpose acquisition company, in its business combination agreement with Forge Nano, Inc., a leading U.S. based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition technology for artificial intelligence-era chip manufacturing and defense battery applications.
The transaction values Forge Nano at approximately $1.2 billion on a pre-money, pre-merger basis. Upon closing of the transaction, the combined company will operate as Forge Nano, Inc., and its common stock and warrants are expected to trade on Nasdaq under the new ticker symbol “NANO” and “NANOW,” respectively.
The transaction also includes $100 million in new capital committed in a private placement of common stock and warrants. Assuming no redemptions, the transaction would result in a total equity value of approximately $1.595 billion. Proceeds from the transaction are expected to expand the production capacity of both semiconductor tools and battery cells, accelerate Forge Nano’s technology and product roadmap, expand into new verticals such as pharmaceuticals, data centers and quantum computing, and scale customer adoption and establish new ecosystem partnerships.
The boards of directors of Forge Nano and Archimedes II have each unanimously approved the proposed business combination and the transaction is expected to close in the second half of 2026, subject to the approval of Archimedes II shareholders and other customary closing conditions.
The Loeb team is led by Mitchell Nussbaum, co-chair of the firm, and Giovanni Caruso, co-chair of the firm’s Capital Markets & Corporate department and SPACs practice, and included Capital Markets senior counsel Dinh Doan and associates Eryn Gordon and Jon Shields, and Tax partner Natan Leyva.
For more information, please see the companies’ joint press release.
The transaction values Forge Nano at approximately $1.2 billion on a pre-money, pre-merger basis. Upon closing of the transaction, the combined company will operate as Forge Nano, Inc., and its common stock and warrants are expected to trade on Nasdaq under the new ticker symbol “NANO” and “NANOW,” respectively.
The transaction also includes $100 million in new capital committed in a private placement of common stock and warrants. Assuming no redemptions, the transaction would result in a total equity value of approximately $1.595 billion. Proceeds from the transaction are expected to expand the production capacity of both semiconductor tools and battery cells, accelerate Forge Nano’s technology and product roadmap, expand into new verticals such as pharmaceuticals, data centers and quantum computing, and scale customer adoption and establish new ecosystem partnerships.
The boards of directors of Forge Nano and Archimedes II have each unanimously approved the proposed business combination and the transaction is expected to close in the second half of 2026, subject to the approval of Archimedes II shareholders and other customary closing conditions.
The Loeb team is led by Mitchell Nussbaum, co-chair of the firm, and Giovanni Caruso, co-chair of the firm’s Capital Markets & Corporate department and SPACs practice, and included Capital Markets senior counsel Dinh Doan and associates Eryn Gordon and Jon Shields, and Tax partner Natan Leyva.
For more information, please see the companies’ joint press release.
-
乐博律所联席主席 -
合伙人 -
Senior Counsel
-
Associate -
合伙人